{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:57:53Z","timestamp":1785477473788,"version":"3.56.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"DOI":"10.1038\/s41431-026-02191-x","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:17:07Z","timestamp":1785424627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BRCA1 and BRCA2 population screening in Latvia: feasibility, engagement, and early lessons from a pilot study"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-1194","authenticated-orcid":false,"given":"Arvids","family":"Irmejs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0887-2973","authenticated-orcid":false,"given":"Zanda","family":"Daneberga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Kiploka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Augucevica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneta","family":"Cerneikina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Gailite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agate","family":"Kalcenaua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilva","family":"Kononova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-7366","authenticated-orcid":false,"given":"Emil","family":"Syundyukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edvins","family":"Miklasevics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrine","family":"Bjorvatn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9876-576X","authenticated-orcid":false,"given":"Hildegunn H\u00f8berg","family":"Vetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janis","family":"Gardovskis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"2191_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.004","volume":"34","author":"C Sessa","year":"2023","unstructured":"Sessa C, Balma\u00f1a J, Bielack S, Bogaerts J, Cardoso F, Casali P, et al. Risk reduction and screening of cancer in hereditary breast\u2013ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34:10\u201327. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.004.","journal-title":"Ann Oncol"},{"key":"2191_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s12282-020-01148-2","volume":"28","author":"R Yoshida","year":"2021","unstructured":"Yoshida R. Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28:515\u201327. https:\/\/doi.org\/10.1007\/s12282-020-01148-2.","journal-title":"Breast Cancer"},{"key":"2191_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s10198-018-0986-y","volume":"20","author":"L Delgado-Ortega","year":"2019","unstructured":"Delgado-Ortega L, Oliva-Moreno J, L\u00f3pez-Bastida J, Perestelo-P\u00e9rez L, Serrano-Aguilar P, Linertov\u00e1 R. The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study. Eur J Health Econ. 2019;20:711\u201321. https:\/\/doi.org\/10.1007\/s10198-018-0986-y.","journal-title":"Eur J Health Econ"},{"key":"2191_CR4","doi-asserted-by":"publisher","first-page":"16384","DOI":"10.3390\/ijerph192416384","volume":"19","author":"M Seweryn","year":"2022","unstructured":"Seweryn M, Paj\u0105k B, Zi\u0119ba D, Kolasa K. The direct and indirect costs of breast cancer in Poland: estimates for 2017\u20132019. Int J Environ Res Public Health. 2022;19:16384 https:\/\/doi.org\/10.3390\/ijerph192416384.","journal-title":"Int J Environ Res Public Health"},{"key":"2191_CR5","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","volume":"32","author":"AP Finch","year":"2014","unstructured":"Finch AP, Lubinski J, M\u00f8ller P, Singer CF, Karlan B, Senter L, et al. Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J Clin Oncol. 2014;32:1547\u201353. https:\/\/doi.org\/10.1200\/JCO.2013.53.2820.","journal-title":"J Clin Oncol"},{"key":"2191_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ygyno.2016.08.334","volume":"143","author":"PF Pinsky","year":"2016","unstructured":"Pinsky PF, Yu K, Black A, Sigurdson A, Zhu C, Kramer BS. Extended mortality results for ovarian cancer screening in the PLCO trial with median 15 years follow-up. Gynecol Oncol. 2016;143:270\u20135. https:\/\/doi.org\/10.1016\/j.ygyno.2016.08.334.","journal-title":"Gynecol Oncol"},{"key":"2191_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1146\/annurev-genom-083118-015253","volume":"21","author":"R Manchanda","year":"2020","unstructured":"Manchanda R, Patel S, Gordeev VS, Antoniou A, Weidner N, Evans DG. Population screening for inherited predisposition to breast and ovarian cancer. Annu Rev Genomics Hum Genet. 2020;21:373\u2013412. https:\/\/doi.org\/10.1146\/annurev-genom-083118-015253.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2191_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1136\/jmedgenet-2022-108519","volume":"60","author":"JM Tiller","year":"2023","unstructured":"Tiller JM, McInerny S, Metcalfe SA, Peters H, Jenkins MA, Doyle MA, et al. Population-based BRCA1\/2 testing programmes are highly acceptable in the Jewish community: results of the JeneScreen study. J Med Genet. 2023;60:368\u201376. http:\/\/hdl.handle.net\/10453\/163925.","journal-title":"J Med Genet"},{"key":"2191_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102297","volume":"66","author":"P Lacaze","year":"2023","unstructured":"Lacaze P, Frison S, Winship I, Thomas DM, Foxall R, Ross S. Combined population genomic screening for three high-risk conditions in Australia: a modelling study. EClinicalMedicine. 2023;66:102297. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102297.","journal-title":"EClinicalMedicine"},{"key":"2191_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/gim.2017.231","volume":"20","author":"HW Tuffaha","year":"2018","unstructured":"Tuffaha HW, Melnyk OB, Eckermann S, McAuley SA, Scuffham PA, Haas M. Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genet Med. 2018;20:985\u201394. https:\/\/doi.org\/10.1038\/gim.2017.231.","journal-title":"Genet Med"},{"key":"2191_CR11","unstructured":"Wilson JMG, Jungner G Principles and practice of screening for disease. Geneva: World Health Organization; 1968. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/37650\/WHO_PHP_34.pdf"},{"key":"2191_CR12","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.ajhg.2024.07.013","volume":"111","author":"MT Parsons","year":"2024","unstructured":"Parsons MT, de la Hoya M, Richardson ME, Tudini E, Anderson M, Berkofsky-Fessler W, et al. Evidence-based recommendations for gene-specific ACMG\/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel. Am J Hum Genet. 2024;111:2044\u201358. https:\/\/doi.org\/10.1016\/j.ajhg.2024.07.013.","journal-title":"Am J Hum Genet"},{"key":"2191_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201323. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"2191_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-021-00168-z","author":"P Loza","year":"2021","unstructured":"Loza P, Irmejs A, Daneberga Z, Miklasevics E, Berga-Svitina E, Subatniece S, et al. A novel frequent BRCA1 recurrent variant c.5117G>A (p.Gly1706Glu) identified after 20 years of BRCA1\/2 research in the Baltic region: cohort study and literature review. Hered Cancer Clin Pr. 2021. https:\/\/doi.org\/10.1186\/s13053-021-00168-z.","journal-title":"Hered Cancer Clin Pr"},{"key":"2191_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10689-012-9519-5","volume":"11","author":"I Brozek","year":"2012","unstructured":"Brozek I, Ratajska M, Drozdowska A, Klonowska K, Balabas A, Limon J. Limited significance of family history for presence of BRCA1 gene mutation in Polish breast and ovarian cancer cases. Fam Cancer. 2012;11:351\u20134. https:\/\/doi.org\/10.1007\/s10689-012-9519-5.","journal-title":"Fam Cancer"},{"key":"2191_CR16","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/ejhg.2017.10","volume":"25","author":"JN Kohler","year":"2017","unstructured":"Kohler JN, Turbitt E, Lewis KL, Biesecker B. Personal utility in genomic testing: a systematic literature review. Eur J Hum Genet. 2017;25:662\u20138. https:\/\/doi.org\/10.1038\/ejhg.2017.10.","journal-title":"Eur J Hum Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02191-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:03:22Z","timestamp":1785474202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-026-02191-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":16,"alternative-id":["2191"],"URL":"https:\/\/doi.org\/10.1038\/s41431-026-02191-x","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Central Medical Ethics Committee, Ministry of Health, Republic of Latvia 17.03.2023 Nr. 01-29.1.2\/1351 and from the Genome Research Council of Latvia, 31.03.2023. Nr.A-1\/23-03-20. Prior to study initiation. All participants provided electronic informed consent before enrolment.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}